Background: In recent years, uterus transplantation (UTx) has been applied as the
and 56% did not. In recent times, strong restrictions on surrogacy have been placed by countries on patients who are not citizens of that country. Additionally, a notice from the Japan Society of Obstetrics and Gynecology (JSOG, Opinion for Surrogacy; http://www.jsog.or.jp/ about_us/view/html/kaikoku/H15_4.html (Japanese)) states that "It is not permitted to implement surrogate pregnancy."
In October 2014, a significant news report about a new successful treatment for UFI was issued in Sweden: "Birth of the world's first uterus transplantation (UTx) baby." 9 In this review, the clinical application of UTx in Japan through the history of UTx technology development in the world and the present situation and future prospects in Japan are considered.
| BASIC ANIMAL RESEARCH
The first clinical implementation of UTx was performed in Saudi Arabia in April, 2000. 10 The recipient was a 26 year old woman whose uterus was excised due to post-partum hemorrhage and the donor was a third-party 46 year old woman who was hysterectomized with a resection of bilateral ovarian cysts. Although the transplant surgery itself succeeded, the transplanted uterus had to be removed due to uterine necrosis, with thrombus formation on the 99th postoperative day. The insufficiency of basic studies in this field was pointed out, 11 and since then, basic research using animal species was started.
The animal experiments regarding UTx have been conducted on small animals, such as mice, [12] [13] [14] [15] [16] rats, [17] [18] [19] [20] [21] [22] and rabbits, [23] [24] [25] [26] large animals (including pigs [27] [28] [29] [30] [31] and sheep [32] [33] [34] [35] [36] [37] [38] [39] [40] , and non-human primates like monkeys [41] [42] [43] [44] [45] [46] [47] [48] and baboons. [49] [50] [51] [52] Many results regarding transplantation techniques, postoperative management, immunosuppression methods, and so on have been obtained. [53] [54] [55] [56] [57] [58] [59] However, the significance of basic research using animals might be attenuated because the case number of human UTx is increasing steadily in the world and clinical knowledge has been accumulating. [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] Although the animal experiments might be useful for developing adequate surgical techniques that are associated with UTx, the implementation limits from the viewpoint of animal welfare should be considered further.
| CLINICAL DEVELOPMENT
Based on the fundamental research results mentioned above, the clinical application of UTx again was initiated abroad. In August, 2011, a Turkish team (Akdeniz University Hospital, Antalya, Turkey) reported a UTx from a brain-dead woman. [71] [72] [73] [74] The donor was a 22 year old multi-organ donor who died in a traffic accident and the recipient was a 21 year old woman with MRKH syndrome. A successful pregnancy was achieved by cryopreserved-thawed embryo transfer (ET) in April, 2013, which resulted in a spontaneous abortion. The pregnancies did not result in the birth of babies, even after two trials of ET.
In September, 2012, a UTx between a mother and a daughter was performed at Sahlgrenska University Hospital in Gothenburg, Sweden. 75, 76 Ultimately, UTx procedures from nine living donors were performed. Eight of the recipients had MRKH syndrome (27-38 years old) and one had postoperative cervical carcinoma (33 years old).
As donors, five cases were mothers, and a sister, an aunt, a motherin-law, and a friend of the mother were involved. The average age of the donors was 53 years (37-62 years), five were postmenopausal (three of them had been postmenopausal for ≥5 years). The mean time of the hysterectomy for the donors was 11 h, 37 min (10 h, 17 min to 13 h, 8 min) and the average bleeding volume was 920 mL (300-2400 mL). The mean time that was required for transplantation to the recipient was 4 h, 46 min (4 h, 10 min to 5 h, 56 min) and the average bleeding volume was 670 mL (250-1600 mL). A bladder-vaginal fistula occurred as a postoperative complication in a donor, but it was repaired. Two of the transplanted uteri had to be removed due to thrombosis and repetitive intrauterine infections.
In the postoperative course, menstruation was observed in all patients and rejection was observed in five patients, but it was relieved by steroid administration. 77 
| ETHICAL, LEGAL, AND SOCIAL ISSUES REGARDING UTERUS TRANSPLANTATION
Uterus transplantation is a medical treatment with two aspects: reproductive medicine and an organ transplant. When discussing the ELSI for UTx, it must be remembered that the concepts of third-party ART and organ transplantation are different from culture to culture due to diversified philosophical and religious traditions 79 and that the feelings toward reproduction are different from person to person, even within the same culture. In addition, the ELSI for progressive medical performance will change over time. Furthermore, uterine tissue engineering has been tried in rat models. [80] [81] [82] If the artificial uterus or placenta is able to regenerate, UTx might become unnecessary for the treatment of UFI.
Although many articles from various regions around the world have been published so far, [83] [84] [85] [86] [87] [88] [89] [90] the ELSI of UTx discussed here are applicable to the present situation in Japan.
| Ethics
From the standpoint of reproductive medicine involving a third party, UTx is comparable with surrogacy. [91] [92] [93] [94] As a kind of organ transplant, the problem of transplantation that is unrelated to life-threatening organ use is faced. Although many ethical problems exist regarding the clinical application of UTx, ~80% of Japanese general citizens have accepted UTx ethically, which was higher than the acceptance rate of surrogacy, [95] [96] [97] similar to other countries.
98,99
| Legislation
Japan is a unique country, in which no law is available for reproductive medicine. This medicine is regulated only by a notice of JSOG 
| Social consensus
In order to obtain the social consensus for UTx, the authors organized a society concerning UTx and underwent several meetings, as mentioned below. However, the recognition rate of UTx by general citizens was 10%-15%, even after the successful UTx and live birth in Sweden was reported. 96, 97 Compared to this, the term "surrogacy"
was well known to >80% of them.
Although three other guidelines than those indicated below have been proposed (those of the International Federation of Gynecology and Obstetrics Committee, 100 The Montreal Criteria, 1 and The Indianapolis consensus 101, 102 ), they must be revised in order to adapt to the current conditions of clinical UTx research. 103 was published (Appendix 1). This guideline was sent to JSOG, the Japan Society for Reproductive Medicine (JSRM), and JST for review.
| CURRENT SITUATION IN JAPAN

| Project Team for Uterus Transplantation
At JSOG, a subcommittee on UTx was established within the Ethics
Committee and discussions were made. The JSRM replied that the society would follow JSOG's policy.
In addition, because the authors thought that it was necessary to provide information to the society in general, to discuss the UTx situation, to investigate the consciousness of donors, recipients, and general citizens, and to obtain social consensus, a specific academic society was organized, as stated below.
| Japan Society for Uterus Transplantation
As a place to deepen the social understanding and discussion of UTx, the "Japan Society for Uterus Transplantation" (JSUTx) (www.js-ut. 
| TRENDS IN THE REST OF THE WORLD
| Trends in foreign countries
Following the success in Sweden, the clinical application of UTx is planned and performed in many countries in the world. In September, 2015, planned UTx using deceased donors to 10 recipients (18-36 years old) was revealed at Imperial College, London, UK. Obstetrics (1) Nephrology (1) Anesthesiology (2) Phycology (1) Pathology (1) Medical film photography ( Table 1 shows the summary of clinical UTx procedures that were performed before May, 2017. In total, 24 procedures were performed from 20 living and four deceased donors. Twenty-two (92%) of the recipients were women with MRKH syndrome. Eight (33%) uteri had to be removed due to failure; therefore, it is hard to state that UTx is a reliable procedure.
| International Society for Uterus Transplantation
With 
| FUTURE PROSPECTS FOR CLINICAL APPLICATION IN JAPAN
For patients with UFI, there is no doubt that UTx can be an alternative to surrogacy and adoption. However, this medical treatment requires not only gynecologists and transplant surgeons, but also many medical staff members (Figure 1 ). Psycological support for the recipients and donors of UTx is essential. [114] [115] [116] [117] [118] Of course, even in Japan, UTx cannot be carried out only by the authors' team. The facility that will actually perform UTx needs to 
| CONCLUSION
The present situation and prospects of UTx have been outlined.
Based on these, it cannot be denied that UTx is still under development as a reproductive medicine and organ transplant procedure.
Future efforts will be required to treat patients with UFI successfully. 101, [119] [120] [121] [122] [123] [124] [125] [126] Additonally, in Japan, a collaborative system that is not limited by facilities and specialties should strive to build an "all-Japan" team.
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